A year on, and Barr's Plan B is a huge success. The company is projecting sales of Plan B will double this year, reaching...
A year on, and Barr's Plan B is a huge success. The company is projecting sales of Plan B will double this year, reaching $80 million. The Rx to OTC switch (which will be discussed further in my upcoming Sept. 17 feature) turned into what was expected: a political issue that everyone needed to weigh in on. And yet, you have to say Barr (and organizations like Planned Parenthood) have done a better job at communicating the benefits than the critics have done at articulating the downside. In fact, I'm still not clear on the critics' main point of contention. I know they claim it's less effective than Barr asserts, but even if that's the case, their argument still seems to be limping along.
Have you registered with us yet?
Register now to enjoy more articles and free email bulletins